Cycloscope™ kits include a specific monoclonal antibody pool to identify neoplasic cells and a ready-to-use DNA labeling solution. Cytognos offers several versions of this reagent:

• • Cycloscope™ MM: useful for the evaluation of DNA plasma cell content in Multiple Myeloma (MM) and Monoclonal Gammopathies of Undetermined Significance (MGUS) samples.

  • Cycloscope™ B-ALL: suitable for the evaluation of DNA content on neoplasic B-cell precursors in B lineage Acute Lymphoblastic Leukemia (B-ALL) samples.

  • Cycloscope™ NHL: designed to determine DNA content on neoplasic B-cells in B-lineage, Non Hodgkin Lymphoma (B-NHL) and other B-cell Chronic Lymphoproliferative Diseases (B-CLPD) samples.

  • Cycloscope™ SBC: developed for the screening of DNA content on epithelial cells of bladder cancer urine samples.

  • Cycloscope™ Reagent: ready-to-use DNA labeling solution (propidium iodide, permeabilization reagents and RNase) with an erythrocyte lysing solution.

  • DNA Labeling Solution: ready-to-use solution that contains propidium iodide, permeabilization reagents and RNase.

Manufacturer's webpage: http://www.cytognos.com/index.php/en/reagents/1334-cycloscope